BSX vs OPY · P/E 20, rev $16.75B vs P/E 13, rev $1.43B
Boston Scientific Corp (BSX) versus Oppenheimer Holdings Inc (OPY) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Not investment advice. Open the BSX and OPY stock pages for the full models.
Not investment advice.